Dr. Oz invested millions in businesses regulated by the agency Trump wants him to lead
Dr. Oz holds a plethora of investments in healthcare, pharmaceutical, health insurance and health research companies
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Dr. Mehmet Oz, the medical television personality turned politician, held multiple investments in companies regulated by or closely tied to the federal agency that Donald Trump tapped him to head – opening the door for questions and concerns about a conflict of interest.
Last week, Dr. Oz was nominated to head the Centers for Medicare & Medicaid Services, the agency that provides health insurance coverage to more than 160 million people in the United States through Medicare, Medicaid, the Children’s Health Insurance Program and the Health Insurance Marketplace.
Yet on his 2022 Senate financial disclosure form, Dr. Oz indicated he had at least $280,000 worth of stakes in health insurance companies, such as UnitedHealth Group and Cigna, that work with the government to provide insurance under Medicaid or Medicare.
UnitedHealth Group has the largest share of Medicare Advantage enrollees (42 percent according to the American Medical Association). Dr. Oz is a big supporter of Medicare Advantage – an alternative Medicare plan run by private insurance companies that contract with Medicare.
Though Dr. Oz’s financial disclosure form does not provide an exact investment number, he holds anywhere from $280,000 to $880,000 worth of stake in UnitedHealth Group.
He also listed family stocks that included a $2.4 million investment in Amazon - which operates an online pharmacy.
In total, Dr. Oz holds tens of millions of dollars worth of investments in healthcare, pharmaceutical and tech companies – all of which could benefit or hinder policies laid out or implemented by CMS.
Dr. Oz has holdings in Johnson&Johnson and Bristol-Meyers Squibb. Both manufacture drugs that were part of Medicare’s negotiations to lower prices under Medicare Part D prescription drug costs.
The investments are not a surprise given Dr. Oz is a medical professional and has built a multi-million dollar career on providing medical advice through his television appearances.
However, if Dr. Oz still holds those investments and is confirmed to lead CMS, they could pose a potential conflict of interest, undermining the public’s faith in Dr. Oz’s ability to lead the agency independently.
In the past, other government agency nominees have divested from companies with ties to the agency they head. One analysis from Citizens of Ethics Reform found that most Biden administration cabinet members agreed to divest individual stock holdings in publicly traded companies or privately held businesses.
Attorney General Merrick Garland, Treasury Secretary Janet Yellen, and Secretary of State Antony Blinken all agreed to divest holdings from multiple companies in order to ensure they could perform their duties conflict-free.
It is unclear if Dr. Oz still holds those investments, and if he does, whether he would divest from them should he be confirmed to lead the agency overseeing Medicaid and Medicare.
The Independent has reached out to a contact for Dr. Oz for comment.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments